To read the full post, please click on the title.

PSP Publishes New Databases for Pharmacometrics & Systems Pharmacology

Most people probably associate the disciplines of Pharmacometrics and Systems Pharmacology in the first instance mainly with modelling and simulation.  However, decades ago computer scientists had already pointed out the “garbage-in-garbage-out” (GIGO) principle, emphasizing the reliance of modelers on high-quality data. ...[read more]

Although the critical role of the immune system in cancer has long been recognized, the development of novel oncological pharmacotherapies through specifically targeting the immune system is a relatively new area of research. Key challenges for the effective translation of emerging science ...[read more]

    Friday, 5 May 2017, 11:00AM-12:00PM EDT (UTC -4)

    Modeling and simulation has become an integral and expected part of internal and regulatory decision making, as illustrated by regulatory guidelines and industry best practice guidelines. For example, as a response to a request from the European Medicines Agency (EMA), the...[read more
    Fueled by the pan-cancer genomics landscape and druggable targets discovered in The Cancer Genome Atlas (TCGA), and great successes of clinically actionable pharmacogenetic variants, precision medicine is one of the driving forces for biomedical research. It is becoming...[read more]
    • 15 March 2017
    • Author: Lang Li, PhD
    • Number of views: 536
    • Comments: 0
    Immunotherapy has burst into oncology drug development during recent years by demonstrating some amazing responses in indications earlier associated with a poor prognosis. The immune checkpoint inhibitors act by restoring and stimulating the patient’s own...[read more]
    528 N Washington St, Alexandria, VA 22314 |  Ph: 703.836.6981 |